LILRB1 and Cirrhosis: In HCV patients with cirrhosis, we detected elevated baseline frequencies of selected inhibitory receptors, with increased NKG2A+ CD56dim and CD56bright cells (P = 0.04 for both NK subsets) (Figure 3A), KIRDL2/L3+ CD56dim (P = 0.0009) and CD56bright (P = 0.02) cells (Figure 3B), and CD85j+ CD56dim cells (P = 0.005) (Figure 3C).